Not sure if this was posted previously but it was announced at my CCFA support group meeting tonight:
http://www.fda.gov/NewsEvents/...ements/ucm494227.htm
From what I was told our friends in the UK and elsewhere in Europe are already using it.
Replies sorted oldest to newest
Thanks for posting this! I remember seeing something a year or so ago, but had not seen the recent approval. This is not considered a generic for Remicade, but just similar. They didn't apply for or get approval as interchangeable with Remicade. Still, it is good to have other options. I also am not sure if it would be a cost savings. http://www.medpagetoday.com/rh...logy/arthritis/57239
I wonder if this was the other biologic your doc was talking about that began with "I"? Inflectra.
I also read in another article that if you have to stop one biologic due to antibody formation, you cannot substitute the biosimilar.
Jan 
I had the same question if it was the other drug my Doc was talking about but it will not hit the market until 2018 I believe.
It may be sooner, since it is not in direct competition with Remicade (no application or approval as a substitute/generic status). But, the makers of Remicade are fighting it anyway.
Jan
